Pfizer Stock News

At a stroke, the pharmaceutical company has become nearly $7 billion larger with a new asset.

Dallas, March 11, 2022 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global inflammatory bowel disease treatment market is expected to grow from USD 18.47 billion in 2020 to USD 28.96 billion by 2030, at a CAGR of 4.6% during the forecast period 2021-2030. Inflammatory bowel disease (IBD) is a term for illnesses involving chronic inflammation of the digestive tract. Some common symptoms of IBD are: abdominal pain, weight loss, persistent diarrhea, rectal bleeding and fatigue. Ulcerative colitis and Crohn''s disease are the two most common kinds of IBD. The colon or large intestine are the only parts of the body affected by ulcerative colitis. On the other hand, Crohn''s disease can affect any portion of the gastrointestinal tract, from the mouth to the anus. The last part of the small intestine or the colon, or both, are the most usually affected areas. Anti-inflammatory drugs are frequently used as the first line of treatment against inflammatory bowel disease.

Stocks that traded heavily or had substantial price changes Friday: DocuSign, Zumiez fall; Pfizer, Pearson rise

Pfizer-BioNTech’s chief executive says that his company is moving closer to providing a fourth dose of its COVID-19 vaccine that will cover all existing variants.

A two-month interval between the first and second doses of a COVID vaccine "may be optimal" for some people, the CDC says.

Pfizer CEO Albert Bourla appeared on CNBC exactly two years after Covid was declared a pandemic by the WHO on March 11, 2020.

Pfizer stock rose near its 50-day line Friday after the drug giant wrapped its $6.7 billion takeover of biotech Arena Pharmaceuticals.

Source: [[https://pixabay.com/photos/laboratory-apparatus-equipment-217041/ Pixabay]] Pfizer announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases. Read more… |

Source: REUTERS. Coronavirus was officially declared a pandemic two years ago today (11 March 2020). Ironically today marks the day that Pfizer has been delisted from the New York Stock Exchange. Read more… |

Pfizer (PFE) CEO Albert Bourla said the pharmaceutical company will not further invest in Russia, but will continue to provide its medicines to the country.

Shares of Pfizer Inc. were up 2.0% in trading on Friday after the company said it closed its $6.7 billion acquisition of Arena Pharmaceuticals Inc. Arena is developing treatments for immuno-inflammatory diseases like ulcerative colitis and atopic dermatitis. It has said it expects to share data from a Phase 3 clinical trial testing one of those experimental therapies, etrasimod, in ulcerative colitis patients during the first quarter of his year. Pfizer''s stock has gained 45.0% over the past year, while the broader S&P 500 is up 10.4%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Pfizer CEO Albert Bourla said that his firm is planning to soon send data to the FDA for a fourth COVID-19 vaccine dose, even as much of the world moves on from Covid.

While the majority of stocks in the United States take a hit from the rising inflation in the US, Pfizer stock has registered a 1.42% gain today despite

MANILA — The Philippines has approved the emergency use of Paxlovid, Pfizer’s PFE.N COVID-19 drug, the country’s food and drug agency said on Friday. It is the third COVID-19 drug approved by the agency for emergency use, after Roche’s ROG.S antibody cocktail and Merck & Co Inc’s MRK.N treatment pill. Paxlovid can be used to treat […] The post FDA approves emergency use of Pfizer’s COVID-19 drug Paxlovid appeared first on Interaksyon .

Pfizer''s (PFE) COVID-19 therapy Paxlovid was approved for emergency use in the Philippines, reported Reuters citing the Asian country''s drug regulator.The approval marks a third…